Arkolith/Insider Trading/FBRX/Form 4

Wagner Paul A.

See Remarks, DirectorForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Dec 8, 2023
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2023Buy(P)15K$0.62$9K1.8M
Dec 7, 2023Buy(P)36K$0.58$21K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057989) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML